Endocrinology

Top Story

VIDEO: EMPA-REG, LEADER trial results produce ‘exciting time’ for diabetes care

July 29, 2016

NEW ORLEANS — The results of the EMPA-REG Outcome study and the LEADER trial have expanded physicians’ armamentariums to be able to decrease patients with diabetes risks for cardiovascular disease, according to Amisha Wallia, MD, MS, of Northwestern Memorial Hospital.

FDA News

FDA fast-track designation granted for type 1 diabetes treatment

July 29, 2016
The FDA granted a Fast Track designation to Caladrius Biosciences Inc. for its product candidate CLBS03 for the treatment of type 1 diabetes, according to a press…
In the Journals Plus

Pioglitazone decreases diabetes, stroke risks in patients with prediabetes, cerebrovascular disease

July 29, 2016
In insulin-resistant patients with a recent ischemic stroke or transient ischemic attack, pioglitazone was shown to reduce the risk for developing type 2 diabetes and…
In the Journals Plus

Reproductive span tied to type 2 diabetes risk in postmenopausal women

July 28, 2016
Women who experience menopause before age 46 years or after age 55 years or who have a reproductive span shorter or longer than 30 to 45 years are at increased risk for…
In the Journals Plus

Lifestyle intervention improves health-related quality of life in prediabetes, metabolic syndrome

July 28, 2016
Adults with prediabetes or metabolic syndrome assigned to an intensive 12-month lifestyle intervention program saw improvements in health-related quality of life, as…
More News Headlines »
CME

Obesity Consults® ObesityForum® 2015 Highlights

This activity is supported by an educational grant from Takeda Pharmaceuticals U.S.A., Inc. and Novo Nordisk, Inc.

Obesity has increased dramatically in the past 20 years and is considered a health care epidemic in the United States…
More »
Video
Meeting News Coverage

VIDEO: ADA's Safe at School campaign making progress

June 10, 2016
More »
Featured
Highlights from AACE

Highlights from AACE

CME

Avoiding “Loss of Chance”… Improving the Screening, Treatment, and Referral of Patients with Diabetic Retinopathy

This activity is supported by an educational grant from Genentech, Inc.

Despite a number of effective treatment options, diabetic eye disease is a leading cause of vision loss in the United…
More »
Current Issues
View the Current Issues
morganatic-roan